Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.

Ye BS, Lee S, Yoo H, Chung SJ, Lee YH, Choi Y, Lee PH, Sohn YH, Yun M.

Neurobiol Aging. 2019 Nov 5. pii: S0197-4580(19)30384-7. doi: 10.1016/j.neurobiolaging.2019.10.020. [Epub ahead of print]

PMID:
31791660
2.

Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.

Yoo HS, Choi YH, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH.

Ann Clin Transl Neurol. 2019 Nov;6(11):2251-2260. doi: 10.1002/acn3.50918. Epub 2019 Oct 23.

3.

The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease.

Yoo HS, Chung SJ, Lee PH, Sohn YH, Kang SY.

J Clin Neurol. 2019 Oct;15(4):517-526. doi: 10.3988/jcn.2019.15.4.517.

4.

Effects of Alzheimer's disease and Lewy body disease on subcortical atrophy.

Yoo HS, Lee EC, Chung SJ, Lee YH, Lee SG, Yun M, Lee PH, Sohn YH, Seong JK, Ye BS.

Eur J Neurol. 2019 Sep 5. doi: 10.1111/ene.14080. [Epub ahead of print]

PMID:
31487756
5.

Response to the letter to the editor, "cerebellar repetitive transcranial magnetic stimulation for patients with essential tremor".

Shin HW, Hallett M, Sohn YH.

Parkinsonism Relat Disord. 2019 Sep;66:260. doi: 10.1016/j.parkreldis.2019.07.027. Epub 2019 Jul 22. No abstract available.

PMID:
31353308
6.

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson's disease.

Lee YH, Cha J, Chung SJ, Yoo HS, Sohn YH, Ye BS, Lee PH.

Sci Rep. 2019 Jul 19;9(1):10531. doi: 10.1038/s41598-019-47026-6.

7.

White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.

Chung SJ, Lee YH, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2019 Sep;66:105-109. doi: 10.1016/j.parkreldis.2019.07.019. Epub 2019 Jul 15.

PMID:
31324555
8.

Unmet needs of people with Parkinson's disease: A cross-sectional study.

Lee J, Kim Y, Kim S, Kim Y, Lee YJ, Sohn YH.

J Adv Nurs. 2019 Dec;75(12):3504-3514. doi: 10.1111/jan.14147. Epub 2019 Oct 9.

PMID:
31287176
9.

Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016.

Park DC, Kim SH, Yong D, Suh IB, Kim YR, Yi J, Song W, Song SA, Moon HW, Lee HK, Park KU, Kim S, Jeong SH, Lee J, Jeong J, Kim YK, Lee M, Cho J, Kim JW, Shin KS, Hwang SH, Chung JW, Woo HI, Lee CH, Ryoo N, Chang CL, Kim HS, Kim J, Shin JH, Kim SH, Lee MK, Lee SG, Jang SJ, Lee K, Suh H, Sohn YH, Kwon MJ, Lee HJ, Hong KH, Woo KS, Park CM, Shin JH.

Ann Lab Med. 2019 Nov;39(6):537-544. doi: 10.3343/alm.2019.39.6.537.

10.

A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients.

Kim CY, Park KH, Ahn J, Ahn MD, Cha SC, Kim HS, Kim JM, Kim MJ, Kim TW, Kim YY, Lee JW, Park SW, Sohn YH, Sung KR, Yoo C, Cha JH, Kim YJ, Lee J, Choi J.

J Glaucoma. 2019 Sep;28(9):785-789. doi: 10.1097/IJG.0000000000001312.

PMID:
31233453
11.

Heterogeneous Patterns of Striatal Dopamine Loss in Patients with Young- versus Old-Onset Parkinson's Disease: Impact on Clinical Features.

Chung SJ, Yoo HS, Lee YH, Lee PH, Sohn YH.

J Mov Disord. 2019 May;12(2):113-119. doi: 10.14802/jmd.18064. Epub 2019 May 30.

12.

Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.

Chung SJ, Yoo HS, Lee YH, Lee HS, Ye BS, Sohn YH, Kwon H, Lee PH.

Hum Brain Mapp. 2019 Sep;40(13):3784-3794. doi: 10.1002/hbm.24631. Epub 2019 May 14.

PMID:
31090134
13.

Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease.

Yoo HS, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee PH.

J Neurol. 2019 Jul;266(7):1601-1610. doi: 10.1007/s00415-019-09297-x. Epub 2019 Apr 22.

PMID:
31011798
14.

Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.

Chung SJ, Lee YH, Yoo HS, Sohn YH, Ye BS, Cha J, Lee PH.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1652-1660. doi: 10.1007/s00259-019-04315-6. Epub 2019 Apr 12.

PMID:
30980099
15.

Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.

Chung SJ, Park YH, Yoo HS, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH.

Neurobiol Aging. 2019 Jun;78:168-177. doi: 10.1016/j.neurobiolaging.2019.02.023. Epub 2019 Mar 11.

PMID:
30947112
16.

Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.

Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS.

Neurology. 2019 Apr 23;92(17):e2015-e2026. doi: 10.1212/WNL.0000000000007373. Epub 2019 Apr 3.

PMID:
30944239
17.

Cerebellar repetitive transcranial magnetic stimulation for patients with essential tremor.

Shin HW, Hallett M, Sohn YH.

Parkinsonism Relat Disord. 2019 Jul;64:304-307. doi: 10.1016/j.parkreldis.2019.03.019. Epub 2019 Mar 24.

PMID:
30928207
18.

Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.

Yoo HS, Chung SJ, Lee YH, Lee HS, Ye BS, Sohn YH, Lee PH.

Neurology. 2019 Mar 26;92(13):e1468-e1478. doi: 10.1212/WNL.0000000000007189. Epub 2019 Feb 22.

PMID:
30796137
19.

Dysautonomia is associated with structural and functional alterations in Parkinson disease.

Chung SJ, Bae YJ, Jun S, Yoo HS, Kim SW, Lee YH, Sohn YH, Lee SK, Seong JK, Lee PH.

Neurology. 2019 Mar 26;92(13):e1456-e1467. doi: 10.1212/WNL.0000000000007181. Epub 2019 Feb 22.

PMID:
30796135
20.

Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?

Chung SJ, Yoo HS, Lee HS, Lee PH, Sohn YH.

J Parkinsons Dis. 2019;9(1):241-247. doi: 10.3233/JPD-181512.

PMID:
30741690
21.

Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.

Chung SJ, Park YH, Yun HJ, Kwon H, Yoo HS, Sohn YH, Lee JM, Lee PH.

Eur J Neurol. 2019 May;26(5):766-773. doi: 10.1111/ene.13886. Epub 2019 Jan 20.

PMID:
30565368
22.

Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease.

Chung SJ, Jeon S, Yoo HS, Yoon JH, Lee JE, Kim JS, Kim SJ, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Mov Disord. 2019 Feb;34(2):299-301. doi: 10.1002/mds.27580. Epub 2018 Dec 10. No abstract available.

PMID:
30537370
23.

A Novel Heterozygous ANO3 Mutation with Basal Ganglia Dysfunction in a Patient with Adult-Onset Isolated Segmental Dystonia.

Yoo HS, Lee H, Chung SJ, Lee JS, Hong SK, Lee PH, Kim YJ, Sohn YH, Shin HW.

J Clin Neurol. 2018 Oct;14(4):596-597. doi: 10.3988/jcn.2018.14.4.596. No abstract available.

24.

The presence of depression in de novo Parkinson's disease reflects poor motor compensation.

Lee Y, Oh JS, Chung SJ, Lee JJ, Chung SJ, Moon H, Lee PH, Kim JS, Sohn YH.

PLoS One. 2018 Sep 19;13(9):e0203303. doi: 10.1371/journal.pone.0203303. eCollection 2018.

25.

Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.

Lee YG, Jeon S, Yoo HS, Chung SJ, Lee SK, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS.

Neurobiol Aging. 2018 Dec;72:32-39. doi: 10.1016/j.neurobiolaging.2018.08.007. Epub 2018 Aug 11.

PMID:
30205358
26.

Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease.

Chung SJ, Jeon S, Yoo HS, Kim G, Oh JS, Kim JS, Evans AC, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2019 Jul;64:54-59. doi: 10.1016/j.parkreldis.2018.08.023. Epub 2018 Aug 31.

PMID:
30193817
27.

The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease.

Chung SJ, Yoo HS, Lee HS, Oh JS, Kim JS, Sohn YH, Lee PH.

Clin Nucl Med. 2018 Nov;43(11):787-792. doi: 10.1097/RLU.0000000000002251.

PMID:
30153150
28.

The efficacy and limits of magnetic resonance-guided focused ultrasound pallidotomy for Parkinson's disease: a Phase I clinical trial.

Jung NY, Park CK, Kim M, Lee PH, Sohn YH, Chang JW.

J Neurosurg. 2018 Aug 1:1-9. doi: 10.3171/2018.2.JNS172514. [Epub ahead of print]

PMID:
30095337
29.

Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?

Chung SJ, Yoo HS, Lee HS, Jeong HE, Kim SJ, Oh JS, Kim JS, Sohn YH, Lee PH.

CNS Drugs. 2018 Oct;32(10):971-979. doi: 10.1007/s40263-018-0549-x.

PMID:
30027399
30.

Factors Associated With Uncertainty in Illness Among People With Parkinson's Disease.

Choi M, Lee J, Oh EG, Chu SH, Sohn YH, Park CG.

Clin Nurs Res. 2018 Jul 1:1054773818788492. doi: 10.1177/1054773818788492. [Epub ahead of print]

PMID:
30019611
31.

Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.

Yoo HS, Jeon S, Chung SJ, Yun M, Lee PH, Sohn YH, Evans AC, Ye BS.

Alzheimers Dement. 2018 Oct;14(10):1243-1252. doi: 10.1016/j.jalz.2018.05.010. Epub 2018 Jun 21.

PMID:
29936148
32.

Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.

Chung SJ, Lee Y, Oh JS, Kim JS, Lee PH, Sohn YH.

Parkinsonism Relat Disord. 2018 Aug;53:96-100. doi: 10.1016/j.parkreldis.2018.05.008. Epub 2018 May 10.

PMID:
29776864
33.

The cholinergic contribution to the resting-state functional network in non-demented Parkinson's disease.

Lee Y, Ham JH, Cha J, Park YH, Lee JJ, Sunwoo MK, Hong JY, Sohn YH, Lee JM, Lee PH.

Sci Rep. 2018 May 16;8(1):7683. doi: 10.1038/s41598-018-26075-3.

34.

The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Yoo HS, Chung SJ, Kim SJ, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1585-1595. doi: 10.1007/s00259-018-4019-y. Epub 2018 May 4.

PMID:
29728749
35.

Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery.

Kim KH, Kang SY, Shin DA, Yi S, Ha Y, Kim KN, Sohn YH, Lee PH.

PLoS One. 2018 Apr 9;13(4):e0195749. doi: 10.1371/journal.pone.0195749. eCollection 2018.

36.

Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson's disease.

Lee Y, Park YH, Lee JJ, Sohn YH, Lee JM, Lee PH.

Parkinsonism Relat Disord. 2018 Jul;52:49-54. doi: 10.1016/j.parkreldis.2018.03.023. Epub 2018 Mar 26.

PMID:
29606606
37.

Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.

Chung SJ, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2018 Jun;51:43-48. doi: 10.1016/j.parkreldis.2018.02.048. Epub 2018 Mar 2.

PMID:
29526657
38.

Subjective Cognitive Complaints and Objective Cognitive Impairment in Parkinson's Disease.

Hong JY, Lee Y, Sunwoo MK, Sohn YH, Lee PH.

J Clin Neurol. 2018 Jan;14(1):16-21. doi: 10.3988/jcn.2018.14.1.16. Epub 2017 Oct 31.

39.

Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.

Yoo HS, Chung SJ, Chung SJ, Moon H, Oh JS, Kim JS, Hong JY, Ye BS, Sohn YH, Lee PH.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):423-431. doi: 10.1007/s00259-017-3844-8. Epub 2017 Oct 26.

PMID:
29075830
40.

Does smoking impact dopamine neuronal loss in de novo Parkinson disease?

Lee Y, Oh JS, Chung SJ, Chung SJ, Kim SJ, Nam CM, Lee PH, Kim JS, Sohn YH.

Ann Neurol. 2017 Nov;82(5):850-854. doi: 10.1002/ana.25082. Epub 2017 Oct 31.

PMID:
29059491
41.

Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.

Ye BS, Jeon S, Yoon S, Kang SW, Baik K, Lee Y, Chung SJ, Oh JS, Moon H, Kim JS, Lee PH, Sohn YH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):197-204. doi: 10.1136/jnnp-2017-316075. Epub 2017 Sep 26.

PMID:
28951497
42.

Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa.

Kang SY, Ryu HS, Sunwoo MK, Kim SJ, Baik JS, Park MY, Park HE, Kim JS, Kwon KY, Koh SB, Kim YE, Lee MK, Kim JM, Chung SJ, Sohn YH.

J Mov Disord. 2017 Sep;10(3):123-129. doi: 10.14802/jmd.17048. Epub 2017 Sep 22.

43.

Dementia-Predicting Cognitive Risk Score and Its Correlation with Cortical Thickness in Parkinson Disease.

Ye BS, Jeon S, Ham JH, Lee JJ, Lee JM, Lee HS, Lee PH, Sohn YH.

Dement Geriatr Cogn Disord. 2017;44(3-4):203-212. doi: 10.1159/000479057. Epub 2017 Sep 21.

PMID:
28930751
44.

Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.

Chung SJ, Yoo HS, Moon H, Oh JS, Kim JS, Park YH, Hong JY, Ye BS, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):169-174. doi: 10.1136/jnnp-2017-315873. Epub 2017 Sep 14.

PMID:
28912301
45.

Microstructural white matter alterations in patients with drug induced parkinsonism.

Lee Y, Ho Choi Y, Lee JJ, Lee HS, Sohn YH, Lee JM, Lee PH.

Hum Brain Mapp. 2017 Dec;38(12):6043-6052. doi: 10.1002/hbm.23809. Epub 2017 Sep 12.

PMID:
28901627
46.

Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.

Chung SJ, Lee Y, Lee JJ, Lee PH, Sohn YH.

Eur J Neurol. 2017 Oct;24(10):1314-1319. doi: 10.1111/ene.13388. Epub 2017 Aug 7.

PMID:
28782870
47.

Erratum to: The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group.

Kwon DY, Koh SB, Lee JH, Park HK, Kim HJ, Shin HW, Youn J, Park KW, Choi SA, Kim SJ, Choi SM, Park JY, Jeon BS, Kim JY, Chung SJ, Lee CS, Park JH, Ahn TB, Kim WC, Kim HS, Cheon SM, Kim HT, Lee JY, Kim JS, Kim EJ, Kim JM, Lee KS, Kim JS, Kim MJ, Baik JS, Park KJ, Kim HJ, Park MY, Kang JH, Song SK, Kim YD, Yun JY, Lee HW, Oh HG, Cho J, Song IU, Sohn YH, Lee PH, Kim JW.

J Clin Neurol. 2017 Jul;13(3):315. doi: 10.3988/jcn.2017.13.3.315.

48.

Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.

Chung SJ, Shin JH, Cho KH, Lee Y, Sohn YH, Seong JK, Lee PH.

Mov Disord. 2017 Oct;32(10):1447-1456. doi: 10.1002/mds.27106. Epub 2017 Jul 24.

PMID:
28737237
49.

Periodically Patterned Au-TiO2 Heterostructures for Photoelectrochemical Sensor.

Guo L, Li Z, Marcus K, Navarro S, Liang K, Zhou L, Mani PD, Florczyk SJ, Coffey KR, Orlovskaya N, Sohn YH, Yang Y.

ACS Sens. 2017 May 26;2(5):621-625. doi: 10.1021/acssensors.7b00251. Epub 2017 May 17.

PMID:
28723172
50.

Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone.

Park J, Kim Y, Youn J, Lee PH, Sohn YH, Koh SB, Lee JY, Baik JS, Cho JW.

Neurol India. 2017 Jul-Aug;65(4):746-751. doi: 10.4103/neuroindia.NI_597_16.

Supplemental Content

Support Center